-
1دورية أكاديمية
المؤلفون: Naidoo, Jarushka, Sima, Camelia S., Rodriguez, Katherine, Busby, Natalie, Nafa, Khedoudja, Ladanyi, Marc, Riely, Gregory J., Kris, Mark G., Arcila, Maria E., Yu, Helena A.
المصدر: Cancer (0008543X); Sep2015, Vol. 121 Issue 18, p3212-3220, 10p
مصطلحات موضوعية: LUNG cancer treatment, CANCER treatment, ADENOCARCINOMA, ERLOTINIB, EPIDERMAL growth factor receptors, EXONS (Genetics), PROTEIN-tyrosine kinase inhibitors, DRUG resistance in cancer cells, THERAPEUTICS
-
2دورية أكاديمية
المؤلفون: Jänne, Pasi A1,2 pasi_janne@dfci.harvard.edu, Ou, Sai-Hong I3, Kim, Dong-Wan4, Oxnard, Geoffrey R1, Martins, Renato5, Kris, Mark G6, Dunphy, Frank7, Nishio, Makoto8, O'Connell, Joseph9, Paweletz, Cloud2, Taylor, Ian10, Zhang, Hui11, Goldberg, Zelanna12, Mok, Tony13
المصدر: Lancet Oncology. Dec2014, Vol. 15 Issue 13, p1433-1441. 9p.
مصطلحات موضوعية: *EPIDERMAL growth factor receptors, *NON-small-cell lung carcinoma, *ENZYME inhibitors, *GEFITINIB, *ERLOTINIB, *CANCER treatment, *CLINICAL trials, *THERAPEUTICS